This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Scripps Research Institute. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Rajesh Grover: Innovator in Myeloma Treatment
Introduction
Rajesh Grover is a notable inventor based in Del Mar, California. He has made significant contributions to the field of medical science, particularly in the treatment of multiple myeloma. His innovative work has the potential to improve the lives of patients suffering from this challenging condition.
Latest Patents
Rajesh Grover holds a patent for "Immunoglobulin-binding human mycoplasma antigens and methods of use thereof." This patent outlines methods for alleviating the symptoms of multiple myeloma in patients. It includes strategies for treating and preventing the development of multiple myeloma, particularly in patients at risk, such as those with monoclonal gammopathy of undetermined significance (MGUS). The invention introduces a new class of antigen, MG281 protein, which binds to various immunoglobulins with high affinity. This protein and its derivatives are also proposed for use in treating autoimmune diseases.
Career Highlights
Rajesh Grover is affiliated with the Scripps Research Institute, where he continues to advance his research and innovations. His work is characterized by a commitment to improving patient outcomes through scientific discovery.
Collaborations
Rajesh has collaborated with esteemed colleagues, including Ian A. Wilson and Xueyong Zhu. These partnerships have further enriched his research and contributed to the development of his innovative solutions.
Conclusion
Rajesh Grover's contributions to the field of medical science, particularly in the treatment of multiple myeloma, highlight his role as a significant inventor. His patented methods and collaborations reflect a dedication to advancing healthcare solutions.